1-propanol has been researched along with ubiquinone in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hall, GS; Laidman, DL | 1 |
Gast, P; Hoff, AJ; Lugtenburg, J; Raap, J; Spoyalov, AP; van den Brink, JS; van Liemt, WB | 1 |
Kaupp, M; Malkin, VG; Malkina, OL; Remenyi, C; Vaara, J | 1 |
Cacciotti, L; Caminiti, G; Grieco, F; Iaia, L; Marazzi, G; Massaro, R; Pelliccia, F; Rosano, G; Sposato, B; Volterrani, M | 1 |
Casiglia, E; D'Avino, M; Lenti, S; Mazza, A; Ramazzina, E; Schiavon, L; Zuin, M | 1 |
Andreozzi, S; Dalmaso, S; Fabrizio, A; Marchitto, N; Mauti, M; Raimondi, G; Sindona, F | 1 |
Calvani, R; Di Giorgio, A; Giupponi, B; Landi, F; Martone, AM; Marzetti, E; Nesci, A; Salini, S; Santoliquido, A; Santoro, L; Zazzara, B | 1 |
3 trial(s) available for 1-propanol and ubiquinone
Article | Year |
---|---|
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Berberine; Biological Products; Blood Glucose; Cholesterol; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Medication Adherence; Prospective Studies; Single-Blind Method; Ubiquinone; Xanthophylls | 2011 |
Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
Topics: Berberine; Biological Products; Blood Pressure; Cardiovascular Diseases; Diet; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Health Behavior; Humans; Hypercholesterolemia; Hypertension; Life Style; Lipids; Male; Middle Aged; Risk Factors; Ubiquinone | 2015 |
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial.
Topics: Adult; Aged; Biological Products; Chromium; Citrus; Dietary Supplements; Dyslipidemias; Endothelial Cells; Fatty Acids, Omega-3; Fatty Alcohols; Female; Humans; Lipid Metabolism; Lipids; Male; Middle Aged; Ubiquinone; Xanthophylls | 2019 |
5 other study(ies) available for 1-propanol and ubiquinone
Article | Year |
---|---|
The determination of tocopherols and isoprenoid quinones in the grain and seedlings of wheat (Triticum vulgare).
Topics: 1-Propanol; Chloroform; Chromatography; Chromatography, Gas; Methods; Plant Extracts; Quinones; Spectrophotometry; Triticum; Ubiquinone; Vitamin E | 1968 |
Asymmetric binding of the primary acceptor quinone in reaction centers of the photosynthetic bacterium Rhodobacter sphaeroides R26, probed with Q-band (35 GHz) EPR spectroscopy.
Topics: 1-Propanol; Anions; Electron Spin Resonance Spectroscopy; Molecular Structure; Photosynthetic Reaction Center Complex Proteins; Rhodobacter sphaeroides; Spectroscopy, Fourier Transform Infrared; Ubiquinone | 1994 |
Density functional calculations of electronic g-tensors for semiquinone radical anions. The role of hydrogen bonding and substituent effects.
Topics: 1-Propanol; Anisotropy; Benzoquinones; Electron Spin Resonance Spectroscopy; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Structure-Activity Relationship; Ubiquinone; Water | 2002 |
A close look at coenzyme Q10 and policosanol. Do these supplements live up to their claims for improving heart health?
Topics: Anticholesteremic Agents; Attitude to Health; Cardiovascular Diseases; Coenzymes; Fatty Alcohols; Health Promotion; Humans; Hypercholesterolemia; Hypertension; Platelet Aggregation Inhibitors; Quality of Life; Self Medication; Ubiquinone; United States | 2002 |
Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
Topics: Berberine; Biological Products; Cassia; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Treatment Outcome; Ubiquinone; Xanthophylls | 2018 |